title: Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression.
authors.forename: Yu-Yan
authors.initials: YY
authors.lastname: Hwang
authors.forename: Kai Y
authors.initials: KY
authors.lastname: Wong
authors.forename: Rock Y Y
authors.initials: RY
authors.lastname: Leung
authors.forename: Simon H M
authors.initials: SH
authors.lastname: Wong
authors.forename: See-Ching
authors.initials: SC
authors.lastname: Chan
authors.forename: Gopesh
authors.initials: G
authors.lastname: Srivastava
authors.forename: Wing Y
authors.initials: WY
authors.lastname: Au
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000235:genetics / Q000378:metabolism*; D001483:Base Sequence; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000473:pathology*; D017809:Fatal Outcome; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000096:biosynthesis / Q000235:genetics; D016031:Liver Transplantation / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008875:Middle Aged; D008969:Molecular Sequence Data; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007147:Immunoglobulin Light Chains; D000069283:Rituximab